Collaborating on a Multi-Component intervention to increase Lung Cancer Screening uptake

合作开展多方面干预措施以提高肺癌筛查的采用率

基本信息

  • 批准号:
    10408362
  • 负责人:
  • 金额:
    $ 15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-04 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Abstract/Project Summary: NCCC is the only NCI-designated Comprehensive Cancer Center in the Northern New England region (i.e., VT, NH, ME). NCCC has a bi-state catchment area comprised of New Hampshire and Vermont that is impacted by high lung cancer incidence and mortality rates. The CDC-funded VT Cancer Plan for 2021-2025, while not final, will include a goal to increase lung cancer screening (LCS) uptake—as only 15% of eligible Vermonters were up-to-date with screening in 2017. VT’s cancer coalition, Vermonters Taking Action Against Cancer (VTAAC), convenes individuals and organizations from across VT (including NCCC and project partners the American Lung Association, Vermont Department of Health, and University of Vermont Medical Center) to help implement the Cancer Plan. VTAAC has an existing Task Force infrastructure to bring together partners focused on specific areas of the cancer plan—including an LCS Task Force. While this infrastructure has supported connections, networking, and cooperation among partners, VTAAC’s Steering Committee and NCCC would like to foster deeper, collaborative relationships in which partners—including NCCC—co-implement and co-evaluate projects. We will pilot an enhanced Task Force model with the LCS Task Force, building its capacity to truly collaborate on a shared project by providing funding for the lead organization, convening the group specifically for project collaboration, assessing the Task Force’s membership, and reviewing project evaluation results and jointly determining future directions for sustained collaboration. Drawing on The Community Guide’s robust evidence-base for interventions that effectively increase uptake of other cancer screenings, we will collaborate with the VTAAC LCS Task Force and its members to co-implement and co-evaluate a multicomponent intervention to increase LCS uptake while addressing known barriers to LCS in our catchment. The intervention will include: 1) an educational campaign to increase community demand for LCS; 2) transportation programs and streamlined appointment scheduling to increase community access; 3) and continuing education, provider reminders, and provider assessment/feedback to increase provider delivery of LCS referrals. The LCS Task Force will review the evaluation results and determine which components to sustain and scale with additional partners based on impact and feasibility. To further sustain our enhanced partnership and optimize the opportunities for collaboration, we will conduct a modified Delphi technique to seek consensus on the broader coalition’s top priorities, we will support the development of new Task Forces aligned with those priorities, and we will seek collaborative funding. To facilitate engagement of additional NCCC investigators with VTAAC, we will conduct an in-reach assessment of NCCC Cancer Population Science Research Program investigators’ areas of expertise, train them on community engagement principles, and match them with the appropriate VTAAC Task Forces.
摘要/项目摘要:NCCC是北方唯一一家由NCI指定的综合性癌症中心。 新英格兰地区(即,VT、NH、ME)。NCCC有一个由新罕布什尔州 和佛蒙特州,受肺癌高发病率和死亡率影响。CDC资助的VT癌症 2021-2025年的计划,虽然不是最终的,但将包括一个增加肺癌筛查(LCS)的目标, 15%符合条件的佛蒙特州人在2017年进行了最新的筛查。佛蒙特州的癌症联盟,佛蒙特州采取 抗癌行动(VTAAC),召集来自VT各地的个人和组织(包括NCCC和 该项目与美国肺脏协会、佛蒙特州卫生部和佛蒙特大学合作 医疗中心),以帮助实施癌症计划。VTAAC有一个现有的特遣部队基础设施, 合作伙伴一起关注癌症计划的特定领域,包括LCS工作组。虽然这 基础设施支持了合作伙伴之间的连接、联网和合作, 委员会和NCCC希望促进更深层次的合作关系,其中包括 净气候中心-共同执行和共同评价项目。我们会与文康署试行一个加强专责小组的模式 工作队,通过为牵头机构提供资金,建设其能力,以真正就共同项目开展合作 组织,召集专门用于项目合作的小组,评估工作队的 成员资格,审查项目评价结果,共同确定可持续发展的未来方向, 协作利用《社区指南》强大的干预证据基础, 增加其他癌症筛查的使用,我们将与VTAAC LCS工作组及其 成员共同实施和共同评估多成分干预措施,以增加LCS的吸收, 解决我们流域内LCS的已知障碍。干预措施将包括:1)教育运动 增加社区对LCS的需求; 2)交通计划和简化的预约时间安排 增加社区访问; 3)和继续教育,提供者提醒,和提供者 评估/反馈,以增加LCS转介的提供者交付。文康署专责小组会检讨 评估结果,并确定哪些组成部分要维持,并根据 影响和可行性。为了进一步维持我们加强的伙伴关系, 合作,我们将进行修改后的德尔菲技术,以寻求更广泛的联盟的最高共识 我们将支持发展与这些优先事项相一致的新的工作队,我们将寻求 合作融资。为了方便更多的NCCC调查员与VTAAC合作,我们将进行 对NCCC癌症人口科学研究计划研究人员的领域进行了深入评估, 专业知识,培训他们社区参与原则,并将其与适当的VTAAC任务相匹配 力.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven D Leach其他文献

Steven D Leach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven D Leach', 18)}}的其他基金

Developing ATAC-array as a novel epigenetic biomarker to guide personalized therapy in pancreatic cancer
开发 ATAC 阵列作为新型表观遗传生物标志物来指导胰腺癌的个性化治疗
  • 批准号:
    10512502
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
Administrative supplement for Early Drug Development Opportunity Program (EDDOP)
早期药物开发机会计划 (EDDOP) 的行政补充
  • 批准号:
    10677500
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
P30 Administrative Supplement to Cancer Center Support Grant to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network.
P30 癌症中心支持补助金的行政补充,旨在通过国家外展网络的社区健康教育者加强 NCI 支持的社区外展能力。
  • 批准号:
    10370916
  • 财政年份:
    2021
  • 资助金额:
    $ 15万
  • 项目类别:
Community-led Action Research in Oncology: Pandemic-appropriate Radiotherapy Innovations Evaluated for LMICs
社区主导的肿瘤学行动研究:针对中低收入国家评估适合流行病的放射治疗创新
  • 批准号:
    10380931
  • 财政年份:
    2021
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9476973
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9922888
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
  • 批准号:
    9080884
  • 财政年份:
    2016
  • 资助金额:
    $ 15万
  • 项目类别:
Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System
斑马鱼系统中人类胰腺癌基因的功能评估
  • 批准号:
    8464656
  • 财政年份:
    2013
  • 资助金额:
    $ 15万
  • 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
  • 批准号:
    8248212
  • 财政年份:
    2011
  • 资助金额:
    $ 15万
  • 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
  • 批准号:
    8095001
  • 财政年份:
    2011
  • 资助金额:
    $ 15万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 15万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 15万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 15万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 15万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 15万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了